Assessing the cost-effectiveness of measles elimination in Uganda: Local impact of a global eradication program

Journal of Infectious Diseases

Volumn 204, Issue SUPPL. 1, 2011, Pages

  Babigumira, Joseph B ^a   Levin, Ann ^b   Burgess, Colleen ^c   Garrison Jr , Louis P ^a   Bauch, Chris T ^d   Braka, Fiona ^e   Mbabazi, William B ^e   Nabyonga, Juliet O ^e   Simons, Emily ^a   Dabbagh, Alya ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Independent Department   (United States)

^c MathEcology LLC   (United States)

^d UNIVERSITY OF GUELPH   (Canada)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES VACCINE;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ASSESSMENT TOOL; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DISABILITY ADJUSTED LIFE YEAR; DISEASE CONTROL; DISEASE TRANSMISSION; ECONOMIC EVALUATION; HEALTH CARE COST; HEALTH CARE MANAGEMENT; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; IMMUNIZATION; INCREMENTAL COST EFFECTIVENESS RATIO; MAJOR CLINICAL STUDY; MEASLES; MORTALITY; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; UGANDA; ECONOMICS; HEALTH; IMMUNOLOGY; INCIDENCE; INTERNATIONAL COOPERATION; ORGANIZATION AND MANAGEMENT; PREVENTIVE HEALTH SERVICE; STATISTICAL MODEL;

COST-BENEFIT ANALYSIS; HUMANS; IMMUNIZATION PROGRAMS; INCIDENCE; INTERNATIONAL COOPERATION; MEASLES; MEASLES VACCINE; MODELS, ECONOMIC; UGANDA; WORLD HEALTH;

EID: 79960862014     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir132     Document Type: Article

References (21)

1. World Health Organization. GIVS: global immunization vision and strategy 2006-2015. Geneva, Switzerland: World Health Organization and UNICEF, 2005. http://www.who.int/vaccines-documents/docspdf05/givs-final-en.pdf. Accessed 24 August 2010.
2. Mbabazi WB, Nanyunja M, Makumbi I, et al. Achieving measles control: lessons from the 2002-06 measles control strategy for Uganda. Health Policy Plan 2009; 24:261-9.
3. World Health Organization. Sixty-Third World Health Assembly: Provisional Agenda Item 11.15 (A63/18). Global eradication of measles. 25 March 2010 http://apps.who.int/gb/ebwha/pdf-files/WHA63/A63-18-en.pdf. Accessed 1 September 2010.
4. Moss WJ, Griffin DE. Global measles elimination. Nat Rev Microbiol 2006; 4:900-8.
5. Levin A, Burgess C, Garrison LP, et al. Global eradication of measles: an epidemiologic and economic evaluation. J Infect Dis 2011; 203(suppl 1). doi:10.1093/infdis/JIR096.
6. United Nations Population Division. http://www.un.org/esa/population/. Accessed 1 September 2010.
7. Garrison LP Jr., Mansley EC, Abbott TA, et al. Good research practices for measuring drug costs in cost-effectiveness analyses: a societal perspective: the ISPOR Drug Cost Task Force report-part II. Value Health 2010; 13:8-13.
8. Gold MR, Siegel JE, Russell LB, Weinstein MC eds. Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996.
9. Murray CJ, Lauer JA, Hutubessy RC, et al. Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk. Lancet 2003; 361:717-25.
10. Goldie SJ, Yazdanpanah Y, Losina E, et al. Cost-effectiveness of HIV treatment in resource-poor settings-the case of Cote d'Ivoire. N Engl J Med 2006; 355:1141-53.
11. Babigumira JB, Sethi AK, Smyth KA, Singer ME. Cost effectiveness of facility-based care, home-based care and mobile clinics for provision of antiretroviral therapy in Uganda. Pharmacoeconomics 2009; 27:963-73.
12. World factbook-Uganda. Central Intelligence Agency website. https://www.cia.gov/library/publications/the-world-factbook/geos/ug.html. Accessed 13 July 2010.
13. Dayan GH, Cairns L, Sangrujee N, Mtonga A, Nguyen V, Strebel P. Cost-effectiveness of three different vaccination strategies against measles in Zambian children. Vaccine 2004; 22:475-84.
14. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL eds. Methods for the economic evaluation of health care programmes. New York: Oxford University Press, 2005.
15. Nanyunja M, Lewis RF, Makumbi I, et al. Impact of mass measles campaigns among children less than 5 years old in Uganda. J Infect Dis 2003; 187(suppl 1):S63-8.
16. Mupere E, Karamagi C, Zirembuzi G, et al. Measles vaccination effectiveness among children under 5 years of age in Kampala, Uganda. Vaccine 2006; 24:4111-5.
17. Siskind D, Baingana F, Kim J. Cost-effectiveness of group psychotherapy for depression in Uganda. J Ment Health Policy Econ 2008; 11:127-33.
18. Marseille E, Kahn JG, Pitter C, et al. The cost effectiveness of home-based provision of antiretroviral therapy in rural Uganda. Appl Health Econ Health Policy 2009; 7:229-43.
19. Fiedler JL, Afidra R. Vitamin A fortification in Uganda: comparing the feasibility, coverage, costs, and cost-effectiveness of fortifying vegetable oil and sugar. Food Nutr Bull 2010; 31:193-205.
20. Bishai D, Asiimwe B, Abbas S, Hyder AA, Bazeyo W. Cost-effectiveness of traffic enforcement: case study from Uganda. Inj Prev 2008; 14:223-7.
21. Bauch CT, Earn DJD. Vaccination and the theory of games. Proc Natl Acad Sci U S A 2004; 101:13391-4.